Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.7%

1 terminated/withdrawn out of 151 trials

Success Rate

95.2%

+8.7% vs industry average

Late-Stage Pipeline

14%

21 trials in Phase 3/4

Results Transparency

0%

0 of 20 completed trials have results

Key Signals

51 recruiting

Enrollment Performance

Analytics

N/A
46(40.7%)
Phase 1
19(16.8%)
Phase 2
19(16.8%)
Phase 3
11(9.7%)
Phase 4
10(8.8%)
Early Phase 1
8(7.1%)
113Total
N/A(46)
Phase 1(19)
Phase 2(19)
Phase 3(11)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (151)

Showing 20 of 151 trials
NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT06790810Completed

Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)

Role: collaborator

NCT07413835Not ApplicableRecruiting

Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)

Role: lead

NCT07446452Phase 2Recruiting

Disitamab Vedotin Plus Bevacizumab in HER2-Low Metastatic Breast Cancer After T-DXd Failure: A Phase II Study

Role: collaborator

NCT07236801Phase 1Recruiting

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Role: collaborator

NCT07410377Early Phase 1Not Yet Recruiting

UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

Role: lead

NCT06397963Not ApplicableRecruiting

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Role: collaborator

NCT07332858Phase 1Not Yet Recruiting

First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion

Role: collaborator

NCT07331454Phase 3Not Yet Recruiting

Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer

Role: collaborator

NCT07315035Phase 2Not Yet Recruiting

QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer

Role: collaborator

NCT07295366Phase 4Recruiting

Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial

Role: lead

NCT07301372Phase 4Recruiting

Evaluation Study of Early Administration of Evolocumab After Thrombolysis in Patients With Atherosclerotic Acute Ischemic Stroke

Role: lead

NCT07285395Phase 1Recruiting

AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study

Role: lead

NCT06818305Phase 2Terminated

Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT

Role: collaborator

NCT06683131Phase 4Not Yet Recruiting

Effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor Initiation Before Percutaneous Coronary Intervention on Acute Myocardial Infarction Patients

Role: lead

NCT07231523Phase 3Not Yet Recruiting

EFG vs IVIG in TAMG

Role: collaborator

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT06088472Phase 1Recruiting

TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors

Role: collaborator

NCT07163299Phase 1Enrolling By Invitation

Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic Stroke

Role: collaborator

NCT06256419Not ApplicableRecruiting

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Role: lead